Accuray to Report Third Quarter Fiscal 2025 Financial Results on April 30, 2025

Rhea-AI Summary

Accuray (NASDAQ: ARAY) has announced it will release its third quarter fiscal 2025 financial results on April 30, 2025. The company will host a conference call at 1:30 p.m. PT/4:30 p.m. ET on the same day to discuss the results for the quarter ended March 31, 2025.

Investors can access the conference call via USA dial-in (1-833-316-0563) or international dial-in (1-412-317-5747). A replay will be available for one week through 1-877-344-7529 (USA) or 1-412-317-0088 (international) using conference ID 8141169. Additionally, a live webcast will be accessible through the company's Investor Relations website at investors.accuray.com, with the replay available until Q4 FY2025 results announcement.

News Market Reaction – ARAY

+1.37%

1 alert

+1.37% News Effect

On the day this news was published, ARAY gained 1.37%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

MADISON, Wis., April 16, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2025, ended March 31, 2025, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on April 30, 2025.

The conference call dial-in numbers are 1-833-316-0563 (USA) or 1-412-317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call's conclusion for one week. The replay number is 1-877-344-7529 (USA) or 1-412-317-0088 (international), conference ID: 8141169.

A live webcast of the call will also be available from the Investor Relations section of the company's website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the fourth quarter of fiscal 2025.

About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, X, and YouTube.

Investor Contact
Aman Patel, CFA
Investor Relations, ICR Healthcare
+1 (443) 450-4191
aman.patel@westwicke.com 

Media Contact
Beth Kaplan
Public Relations Director, Accuray
+1 (408) 789-4426
bkaplan@accuray.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-third-quarter-fiscal-2025-financial-results-on-april-30-2025-302429891.html

SOURCE Accuray Incorporated

FAQ

When will Accuray (ARAY) report Q3 2025 earnings?

Accuray will report its Q3 fiscal 2025 earnings on April 30, 2025, at 1:30 p.m. PT/4:30 p.m. ET.

How can investors access Accuray's (ARAY) Q3 2025 earnings call?

Investors can join via phone (1-833-316-0563 USA, 1-412-317-5747 international) or watch the webcast at investors.accuray.com.

How long will Accuray's (ARAY) Q3 2025 earnings call replay be available?

The conference call replay will be available for one week, while the webcast replay will remain accessible until Q4 FY2025 results are announced.

What is the conference ID for Accuray's (ARAY) Q3 2025 earnings call replay?

The conference ID for the earnings call replay is 8141169.